Search research articles
Contact Us
Filters
Showing results (521-530 of 603) with videos related to
Page
of 61
Sort By:
Expert Review of Hematology
|
March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders
Robert F Sidonio, Paulette C Bryant, Jorge Di Paola, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 14, 2021
A comparative analysis between low-dose-rate brachytherapy and external beam radiation therapy for low- and intermediate-risk prostate cancer in Asian men
Youquan Li, Thomas Chan Kong Ngai, Siqin Zhou, et al.
Acta Haematologica
|
June 2, 2024
Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies
Lindsey E Roeker, Catherine C Coombs, Nirav N Shah, et al.
Journal of the American Academy of Dermatology
|
May 20, 2020
Deep learning for dermatologists: Part II. Current applications
Pranav Puri, Nneka Comfere, Lisa A Drage, et al.
Leukemia & Lymphoma
|
January 24, 2020
Pretreatment SUV<sub>max</sub> may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL
Paolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.
Cancer
|
May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma
Jorge E Romaguera, Michael Wang, Lei Feng, et al.
Nature
|
June 21, 2019
Helical van der Waals crystals with discretized Eshelby twist
Yin Liu, Jie Wang, Sujung Kim, et al.
Blood
|
July 22, 2016
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
Hervé Avet-Loiseau, Rafael Fonseca, David Siegel, et al.
Neurosurgery
|
July 24, 2015
Prediction of Quality of Life and Survival After Surgery for Symptomatic Spinal Metastases: A Multicenter Cohort Study to Determine Suitability for Surgical Treatment
David Choi, Zoe Fox, Todd Albert, et al.
Cell Reports
|
March 17, 2021
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
Xiaohong Zhao, Michelle Y Wang, Huijuan Jiang, et al.
Page
of 61
Search research articles
Search
Showing results (521-530 of 603) with videos related to
Sort By:
Page
of 61
Expert Review of Hematology
|
March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders
Robert F Sidonio, Paulette C Bryant, Jorge Di Paola, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 14, 2021
A comparative analysis between low-dose-rate brachytherapy and external beam radiation therapy for low- and intermediate-risk prostate cancer in Asian men
Youquan Li, Thomas Chan Kong Ngai, Siqin Zhou, et al.
Acta Haematologica
|
June 2, 2024
Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies
Lindsey E Roeker, Catherine C Coombs, Nirav N Shah, et al.
Journal of the American Academy of Dermatology
|
May 20, 2020
Deep learning for dermatologists: Part II. Current applications
Pranav Puri, Nneka Comfere, Lisa A Drage, et al.
Leukemia & Lymphoma
|
January 24, 2020
Pretreatment SUV<sub>max</sub> may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL
Paolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.
Cancer
|
May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma
Jorge E Romaguera, Michael Wang, Lei Feng, et al.
Nature
|
June 21, 2019
Helical van der Waals crystals with discretized Eshelby twist
Yin Liu, Jie Wang, Sujung Kim, et al.
Blood
|
July 22, 2016
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
Hervé Avet-Loiseau, Rafael Fonseca, David Siegel, et al.
Neurosurgery
|
July 24, 2015
Prediction of Quality of Life and Survival After Surgery for Symptomatic Spinal Metastases: A Multicenter Cohort Study to Determine Suitability for Surgical Treatment
David Choi, Zoe Fox, Todd Albert, et al.
Cell Reports
|
March 17, 2021
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
Xiaohong Zhao, Michelle Y Wang, Huijuan Jiang, et al.
Page
of 61